Anti-cancer cytokines

Drug Profile

Anti-cancer cytokines

Alternative Names: TNF enhancing cytokines; Tumour active cytokines

Latest Information Update: 17 Feb 2003

Price : $50

At a glance

  • Originator BioPulse International [CEASED]
  • Class
  • Mechanism of Action Tumour necrosis factor stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cancer

Most Recent Events

  • 17 Feb 2003 Discontinued - Clinical-Phase-Unknown for Cancer in USA (unspecified route)
  • 04 Dec 2000 New profile
  • 04 Dec 2000 Investigation in Cancer in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top